Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.81 | N/A |
| PEG Ratio (TTM) | 0.17 | N/A |
| P/S Ratio (TTM) | N/A | N/A |
| P/B Ratio (TTM) | 1.35 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | 21.10 | N/A |
| Price to 5YR AVG FCF Ratio | 23.71 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.55% | N/A |
| ROE (TTM) | 8.17% | N/A |
| Net Profit Margin (TTM) | 21.37% | N/A |
| ROIC 5YR AVG | 11.56% | N/A |
Growth (62%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -3.07% | 2.96% | 9.07% |
| Revenue | -1.78% | 16.26% | 14.60% |
| Net Income | -2.94% | 18.35% | 23.57% |
| Cash Flow | 57.11% | 1,336.68% | 817.66% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.38 | N/A |
| Interest Coverage (TTM) | 2.36 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 1.75 | N/A |
| LTL to 5YR AVG FCF | 6.64 | N/A |
| Shares Outstanding Growth 5YR AVG | 12.21% | N/A |